Chronic Phantom Limb Pain: The Effects of Calcitonin, Ketamine, and Their Combination on Pain and Sensory Thresholds
Authors:
- Urs EichenbergerUEUrs Eichenberger
- Frank NeffFNFrank Neff
- Gorazd SveticicGSGorazd Sveticic
- Steinar BjörgoSBSteinar Björgo
- Steen Petersen-FelixSPSteen Petersen-Felix
- Lars Arendt-NielsenLALars Arendt-Nielsen
- Michele CuratoloMCMichele Curatolo
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 106 (4) , 1265-1273
Abstract
Calcitonin was effective in a study of acute phantom limb pain, but it was not studied in the chronic phase. The overall literature on N-methyl-D-aspartate antagonists is equivocal. We tested the hypothesis that calcitonin, ketamine, and their combination are effective in treating chronic phantom limb pain. Our secondary aim was to improve our understanding of the mechanisms of action of the investigated drugs using quantitative sensory testing. Twenty patients received, in a randomized, double-blind, crossover manner, 4 i.v. infusions of: 200 IE calcitonin; ketamine 0.4 mg/kg (only 10 patients); 200 IE of calcitonin combined with ketamine 0.4 mg/kg; placebo, 0.9% saline. Intensity of phantom pain (visual analog scale) was recorded before, during, at the end, and the 48 h after each infusion. Pain thresholds after electrical, thermal, and pressure stimulation were recorded before and during each infusion. Ketamine, but not calcitonin, reduced phantom limb pain. The combination was not superior to ketamine alone. There was no difference in basal pain thresholds between the amputated and contralateral side except for pressure pain. Pain thresholds were unaffected by calcitonin. The analgesic effect of the combination of calcitonin and ketamine was associated with a significant increase in electrical thresholds, but with no change in pressure and heat thresholds. Our results question the usefulness of calcitonin in chronic phantom limb pain and stress the potential interest of N-methyl-D-aspartate antagonists. Sensory assessments indicated that peripheral mechanisms are unlikely important determinants of phantom limb pain. Ketamine, but not calcitonin, affects central sensitization processes that are probably involved in the pathophysiology of phantom limb pain.Keywords
This publication has 31 references indexed in Scilit:
- A Placebo-Controlled Randomized Crossover Trial of the N-Methyl-d-Aspartic Acid Receptor Antagonist, Memantine, in Patients with Chronic Phantom Limb PainAnesthesia & Analgesia, 2004
- Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteersActa Anaesthesiologica Scandinavica, 2003
- Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteersBiopharmaceutics & Drug Disposition, 2002
- Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind‐up of the second pain response in healthy male volunteersBritish Journal of Clinical Pharmacology, 2002
- Effect of Oral Ketamine on Secondary Hyperalgesia, Thermal and Mechanical Pain Thresholds, and Sedation in HumansRegional Anesthesia & Pain Medicine, 2000
- The Effects of Ketamine on the Temporal Summation (Wind-Up) of the RIII Nociceptive Flexion Reflex and Pain in HumansAnesthesia & Analgesia, 2000
- The influence of preamputation pain on postamputation stump and phantom painPain, 1997
- The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral inputPain, 1996
- Calcitonin in phantom limb pain: a double-blind studyPain, 1992
- Characteristics of second pain and flexion reflexes indicative of prolonged central summationExperimental Neurology, 1972